FOXP3 and neoplasm: CTLA-4 antibody induces anti-tumor immunity by blocking Foxp3+Treg cells in the tumor microenvironment and AKT phosphorylation pathway, effectively amplifying T cells and enhancing the anti-tumor effect 8.